Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
0.80%
27.04.24

Risky Investment
Global_Player 
25.04.24 50%
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.66
14.04.24
-
14.04.25
-13.86%
28.04.24

Could be worthwhile Investment >10% per year
thomasw 
14.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€22.07
13.04.24
€2.00
13.04.25
-5.44%
27.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
nvestor 
13.04.24 50%
sell
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€1.06
26.03.24
-
26.03.25
-1.69%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
sell
Regulus Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.22
12.03.24
-
12.03.25
-9.01%
16.03.24

Probably not worthwhile Investment
daimler1 
12.03.24 50%
sell
Energy Focus Inc.

Start price
Target price
Perf. (%)
€1.59
21.02.24
-
21.02.25
3.14%
02.03.24

Capable Management
No uniques
Probably not worthwhile Investment
Little innovation
me8 
21.02.24 0%
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.08
21.01.24
-
21.01.25
21.10%
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
21.01.24 50%
buy
Altimmune

Start price
Target price
Perf. (%)
€8.54
21.01.24
-
21.01.25
-0.30%
03.02.24

Could be very worthwhile Investment >20% year
thomasw 
21.01.24 50%
sell
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€3.44
20.01.24
€1.00
20.01.25
3.49%
03.02.24

High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
mixitrader 
20.01.24 50%
sell
Gevo Inc.

Start price
Target price
Perf. (%)
€0.80
19.01.24
-
19.02.24
-1.13%
22.01.24

Risky Investment
Lokrim 
19.01.24 50%
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.62
07.01.24
-
07.01.25
-11.80%
20.01.24

Could be worthwhile Investment >10% per year
daimler1 
07.01.24 50%
sell
Gevo Inc.

Start price
Target price
Perf. (%)
€1.01
07.01.24
-
07.01.25
-20.87%
19.01.24

Risky Investment
Lokrim 
07.01.24 20%
buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.74
03.01.24
-
03.01.25
-3.65%
06.01.24

Risky Investment
michaelkr 
03.01.24 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€13.80
10.12.23
€40.00
10.12.24
-19.13%
26.03.24

Could be very worthwhile Investment >20% year
Rising EBIT margin expected
High Investments for future growth
Very valuable balance sheet
WatchMen 
10.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€7.40
09.12.23
€1.00
09.12.24
29.19%
09.02.24

overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
Marianka 
09.12.23 70%
buy
Altimmune

Start price
Target price
Perf. (%)
€7.40
09.12.23
€13.00
09.12.24
15.03%
04.02.24

overvalued
negative Cash Flow expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
dimontalban 
09.12.23 60%
buy
Lazydays Holdings Inc

Start price
Target price
Perf. (%)
€7.25
04.12.23
€14.00
04.12.24
-26.90%
04.01.24

Could be very worthwhile Investment >20% year
DomRuinart 
04.12.23 50%
buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.34
02.12.23
€4.00
31.12.25
12.82%
07.01.24

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 60%
buy
Cemtrex Inc.

Start price
Target price
Perf. (%)
€0.25
02.12.23
€7.00
31.01.26
-
04.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
Marianka 
02.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
dimontalban 
02.12.23 70%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€2.46
28.11.23
€0.000
28.11.24
26.83%
09.12.23

Risky Investment
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
Marianka 
28.11.23 50%
buy
Gevo Inc.

Start price
Target price
Perf. (%)
€1.05
27.11.23
€8.00
27.11.24
4.87%
09.12.23

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Revenue decline/stagnation expected
EBIT decline/stagnation expected
dimontalban 
27.11.23 50%
buy
Gevo Inc.

Start price
Target price
Perf. (%)
€1.08
26.11.23
€1.00
26.11.24
1.24%
11.12.23

Probably not worthwhile Investment
negative Cash Flow expected
Low dividend yield expected
High valuation
ReynadJ 
26.11.23 40%